ELDN
Eledon Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Eledon Pharmaceuticals (ELDN) Stock: Buy, Sell, or Hold?
$2.67
-0.09 (-3.26%)
▼
5d:
-1.11%
30d:
+14.1%
90d:
-27.84%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 13, 2026
TODAY
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$2.25 – $2.68
Position: EXTENDED
Forward P/E & Valuation
-3.5x
Next 12M consensus est.
Wall Street Target
$9.00
+237.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.38 / $3.22
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ELDN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ELDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ELDN is currently trading at $2.67, which is considered extended relative to its 30-day fair value range of $2.25 to $2.68.
Technical Outlook: Technically, ELDN is in a strong downtrend. Immediate support is located at $2.38, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ELDN scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.00 (+237.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELDN is in a strong downtrend. Immediate support is located at $2.38, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ELDN scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.00 (+237.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.25 -
$2.68
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$2.25 -
$2.68
Current vs Trading Range
EXTENDED
Support Level
$2.38
Resistance Level
$3.22
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 237.1% below Wall St target ($9.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.47
Wall Street Target
$9.00
(+237.1%)
Share ELDN Analysis
Share this live ELDN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ELDN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Positive sentiment on StockTwits regarding $ELDN following a news article published on AJMC about Tegoprof reducing symptom burden compared to Tacrolimus after kidney transplant.
Key Retail Themes:
Positive clinical trial results
Competitive advantage
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:04 AM ET
Data refreshes hourly during market hours. Next update: 9:04 AM
Data refreshes hourly during market hours. Next update: 9:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ELDN Research Pages
